InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Perry Michael S, Director. Director active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 17 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €3.2m. Activity tracked since 2 June 2021. The latest transaction was disclosed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Perry Michael S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
11,600 股@ US$87.30Common StockSEC:0001250379-26-000002:0
7,819 股0Common StockSEC:0001250379-25-000005:0
16,250 股@ US$61.030.042% mcap42.6% 占其流量Common StockSEC:0001250379-25-000003:0
16,733 股@ US$22.9913.5% 占其流量Common StockSEC:0001628280-24-052269:0
14,987 股@ US$25.4112.8% 占其流量Common StockSEC:0001628280-23-041967:0
7,867 股0Common StockSEC:0001209191-23-003077:0
150,000 股@ US$5.9933.9% 占其流量Common StockSEC:0001209191-22-058404:0
150,000 股@ US$7.1840.6% 占其流量Common StockSEC:0001209191-22-058404:1
2,980 股0Common StockSEC:0001209191-22-048725:0
23,754 股0Common StockSEC:0001209191-22-033585:0
23,753 股0Common StockSEC:0001209191-22-013222:0
6,400 股0Common StockSEC:0001209191-22-002595:0
2,628 股@ US$64.308.7% 占其流量Common StockSEC:0001209191-22-001318:0
23,800 股Common StockSEC:0001209191-21-071256:0
23,754 股0Common StockSEC:0001209191-21-054958:0
23,000 股@ US$17.3314.6% 占其流量Common StockSEC:0001209191-21-038189:0
30,000 股Common StockSEC:0001209191-16-088058:0
17 条申报中的 17 条
About Perry Michael S
PERRY MICHAEL S is a Director at AVITA Medical, Inc., Arrowhead Pharmaceuticals, INC., and ARROWHEAD RESEARCH CORP. He has 16 filings in total, and within the sampled recent filings the period runs from 2016-01-04 to 2025-12-18, with 0 EUR in buys and 2369331 EUR in sells, the most common transaction nature being Attribution.
